Free press releases distribution network?

Agency / Source: Ogilvy Public Relations

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GVK Biosciences Strengthens Focus on 'Development' Services - Appoints Dr. Shoibal Mukherjee as Senior Vice President – Clinical Development
GVK Biosciences Strengthens Focus on 'Development' Services


PRZOOM - /newswire/ - Hyderabad, Andhra Pradesh, India, 2008/12/03 - Appoints Dr. Shoibal Mukherjee as Senior Vice President – Clinical Development.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Biosciences Private Limited (GVK BIO), one of Asia’s leading CROs, today announced the appointment of Dr. Shoibal Mukherjee to the position of Senior Vice President – Clinical Development.
“Expanding and enriching our leadership team is critical for GVK BIO’s vision of being a leading life-sciences services company," said D S Brar, Chairman, GVK BIO. "Dr. Shoibal Mukherjee has extensive experience in managing global clinical trials and will play a pivotal role in the growth of the company’s ‘Development’ services."

Prior to joining GVK BIO, Dr. Mukherjee served in Ranbaxy and Pfizer in senior positions. Dr. Mukherjee graduated as a physician and is an MD and DM in Pharmacology. Professionally trained in clinical & pharmaceutical medicine, Dr. Mukherjee has vast experience in managing Clinical Trials, Medical Affairs, Clinical Data Management, and Clinical Pharmacology. Dr. Mukherjee has authored several research papers and is a visiting faculty for established universities and medical institutions. Dr. Mukherjee is the Founding President of the Indian Society for Clinical Research and a member of several committees.

Dr. Shoibal Mukherjee is the most recent in a series of senior-level appointments at GVK BIO. Earlier this year, GVK BIO had recruited Dr. Sailendra Goswami as Vice President for Clinical Pharmacology. Dr. Goswami previously worked as CEO of Veeda Clinical Research Pvt. Ltd. and played a key role right from its inception.

GVK BIO has also strengthened its international Clinical Research Business Development team by recruiting William Harel as Vice President – Business Development, in the West Coast of USA. A PhD in Immunology, William is responsible for developing the business of Clinical Research in the US and globally. William has over 20 years of experience in various companies including Chiron Corporation, AAI Pharma and Neeman Medical International.

In addition to its well established services in Discovery Research and Informatics, GVK BIO offers Clinical Development services that span Special population studies to Phase II – IV clinical trials, Data Management, Biostatistics, Medical Writing, Pharmacovigilance, Bioequivalence studies, and Bioanalytical services.
"I am delighted to join GVK Biosciences and look forward to making GVK BIO a global clinical development service provider” said Dr.Shoibal Mukherjee on his appointment.


GVK Biosciences Asia’s leading Contract Research Organization, delivers integrated research services to big Pharma and Biotech companies globally. The company accelerates the Drug Discovery and Development process of its customers through science and innovation. Currently the company has more than 1,300 employees spread across facilities in Hyderabad, Chennai, Mumbai and Gurgaon.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Agency / Source: Ogilvy Public Relations


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker


Distribution / Indexing: [+]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

GVK Biosciences Strengthens Focus on 'Development' Services

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Contact: Rucha Sane - 
+91 40 44344325 rucha.sane[.]
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Ogilvy Public Relations securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Press Releases From Ogilvy Public Relations / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...


Visit  RightITnow Ltd



  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today